BNC Wealth Management’s Bio-Techne TECH Stock Holding History

BNC Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-156	Closed	-$10K	–	417
2020 Q3	$10K	Buy	+156	New	+$10.1K	0.01%	304

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNC Wealth Management's TECH Position: Q4 2020 in Review

BNC Wealth Management sold out of Bio-Techne (TECH) in Q4 2020, closing a stake of 156 shares — an estimated $10K sold.

BNC Wealth Management first reported a position in TECH in Q3 2020 and held it in 1 quarter. The position peaked at $10K in Q3 2020. 440 funds tracked by Wall St. Rank hold TECH as of Q4 2020.

BNC Wealth Management reported no remaining Bio-Techne position as of Q4 2020 after selling out during the quarter.
BNC Wealth Management sold 156 Bio-Techne shares in Q4 2020, an estimated $10K.
BNC Wealth Management first reported a position in Bio-Techne in Q3 2020 and held it in 1 quarter.
BNC Wealth Management's Bio-Techne position peaked at $10K in Q3 2020.
440 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2020.

Based on BNC Wealth Management's 13F filing for Q4 2020, filed 5 Mar 2021.